First Trust Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.01M | Sell |
27,466
-476,069
| -95% | -$22.6M | ﹤0.01% | 2156 |
|
|
2025
Q4 | $25.6M | Buy |
503,535
+461,940
| +1,111% | +$23.6M | 0.02% | 805 |
|
|
2025
Q3 | $2.31M | Sell |
41,595
-19,903
| -32% | -$1.17M | ﹤0.01% | 1769 |
|
|
2025
Q2 | $4.24M | Sell |
61,498
-30,873
| -33% | -$2.1M | ﹤0.01% | 1439 |
|
|
2025
Q1 | $6.41M | Sell |
92,371
-487,282
| -84% | -$40.2M | 0.01% | 1203 |
|
|
2024
Q4 | $49.9M | Buy |
579,653
+518,361
| +846% | +$56.1M | 0.04% | 513 |
|
|
2024
Q3 | $7.3M | Sell |
61,292
-331,128
| -84% | -$44.2M | 0.01% | 1158 |
|
|
2024
Q2 | $56M | Sell |
392,420
-119,812
| -23% | -$15.9M | 0.06% | 406 |
|
|
2024
Q1 | $65.8M | Buy |
512,232
+441,343
| +623% | +$52.5M | 0.07% | 372 |
|
|
2023
Q4 | $7.33M | Sell |
70,889
-81,256
| -53% | -$8.04M | 0.01% | 1107 |
|
|
2023
Q3 | $13.8M | Buy |
152,145
+7,611
| +5% | +$670K | 0.02% | 880 |
|
|
2023
Q2 | $11.7M | Sell |
144,534
-154,550
| -52% | -$12.6M | 0.01% | 961 |
|
|
2023
Q1 | $23.8M | Buy |
299,084
+184,808
| +162% | +$13.1M | 0.03% | 673 |
|
|
2022
Q4 | $7.73M | Sell |
114,276
-1,225,232
| -91% | -$71.8M | 0.01% | 1036 |
|
|
2022
Q3 | $66.7M | Buy |
1,339,508
+1,335,810
| +36,122% | +$71.6M | 0.09% | 341 |
|
|
2022
Q2 | $206K | Sell |
3,698
-1,109,810
| -100% | -$61.6M | ﹤0.01% | 2382 |
|
|
2022
Q1 | $61.8M | Sell |
1,113,508
-2,220
| -0.2% | -$114K | 0.06% | 452 |
|
|
2021
Q4 | $62.5M | Sell |
1,115,728
-69,366
| -6% | -$3.76M | 0.06% | 439 |
|
|
2021
Q3 | $56.9M | Sell |
1,185,094
-251,332
| -17% | -$12.2M | 0.06% | 430 |
|
|
2021
Q2 | $60.1M | Sell |
1,436,426
-212,852
| -13% | -$8.25M | 0.07% | 414 |
|
|
2021
Q1 | $55.6M | Buy |
1,649,278
+139,298
| +9% | +$4.96M | 0.07% | 424 |
|
|
2020
Q4 | $52.7M | Sell |
1,509,980
-27,796
| -2% | -$961K | 0.07% | 407 |
|
|
2020
Q3 | $53.4M | Buy |
1,537,776
+168,438
| +12% | +$5.61M | 0.09% | 330 |
|
|
2020
Q2 | $44.8M | Buy |
1,369,338
+29,088
| +2% | +$928K | 0.08% | 369 |
|
|
2020
Q1 | $40.3M | Sell |
1,340,250
-331,248
| -20% | -$9.86M | 0.09% | 364 |
|
|
2019
Q4 | $48.4M | Buy |
1,671,498
+1,663,698
| +21,329% | +$46.1M | 0.08% | 384 |
|
|
2019
Q3 | $202K | Sell |
7,800
-676
| -8% | -$17.1K | ﹤0.01% | 2338 |
|
|
2019
Q2 | $216K | Buy |
+8,476
| New | +$209K | ﹤0.01% | 2344 |
|
|
2019
Q1 | – | Sell |
-40,666
| Closed | -$937K | – | 2443 |
|
|
2018
Q4 | $937K | Sell |
40,666
-980,870
| -96% | -$21.8M | ﹤0.01% | 1856 |
|
|
2018
Q3 | $24.1M | Buy |
1,021,536
+88,274
| +9% | +$2.15M | 0.04% | 538 |
|
|
2018
Q2 | $21.5M | Buy |
933,262
+913,966
| +4,737% | +$21.7M | 0.04% | 536 |
|
|
2018
Q1 | $475K | Sell |
19,296
-38,452
| -67% | -$1.01M | ﹤0.01% | 2035 |
|
|
2017
Q4 | $1.55M | Buy |
57,748
+20,456
| +55% | +$520K | ﹤0.01% | 1660 |
|
|
2017
Q3 | $898K | Sell |
37,292
-63,754
| -63% | -$1.44M | ﹤0.01% | 1886 |
|
|
2017
Q2 | $2.17M | Sell |
101,046
-1,046,276
| -91% | -$21.1M | 0.01% | 1431 |
|
|
2017
Q1 | $19.7M | Buy |
1,147,322
+296,158
| +35% | +$5.16M | 0.05% | 490 |
|
|
2016
Q4 | $15.3M | Buy |
851,164
+251,522
| +42% | +$4.56M | 0.05% | 574 |
|
|
2016
Q3 | $12.5M | Buy |
599,642
+574,646
| +2,299% | +$14.2M | 0.04% | 644 |
|
|
2016
Q2 | $672K | Sell |
24,996
-23,184
| -48% | -$636K | ﹤0.01% | 1865 |
|
|
2016
Q1 | $1.3M | Buy |
48,180
+13,348
| +38% | +$358K | ﹤0.01% | 1542 |
|
|
2015
Q4 | $1.01M | Sell |
34,832
-52,668
| -60% | -$1.46M | ﹤0.01% | 1736 |
|
|
2015
Q3 | $2.37M | Buy |
87,500
+31,782
| +57% | +$900K | 0.01% | 1314 |
|
|
2015
Q2 | $1.53M | Buy |
55,718
+32,232
| +137% | +$906K | ﹤0.01% | 1648 |
|
|
2015
Q1 | $627K | Buy |
+23,486
| New | +$541K | ﹤0.01% | 1910 |
|
|
2014
Q4 | – | Sell |
-11,824
| Closed | -$282K | – | 2294 |
|
|
2014
Q3 | $282K | Sell |
11,824
-28,926
| -71% | -$666K | ﹤0.01% | 2060 |
|
|
2014
Q2 | $941K | Buy |
40,750
+6,286
| +18% | +$139K | ﹤0.01% | 1716 |
|
|
2014
Q1 | $787K | Buy |
34,464
+6,074
| +21% | +$129K | ﹤0.01% | 1778 |
|
|
2013
Q4 | $525K | Sell |
28,390
-1,720
| -6% | -$30K | ﹤0.01% | 1878 |
|
|
2013
Q3 | $510K | Buy |
+30,110
| New | +$506K | ﹤0.01% | 1899 |
|
Other funds holding NVO
DAM
F
First Trust Advisors's NVO Position: Q1 2026 in Review
First Trust Advisors reduced its Novo Nordisk (NVO) stake by 95% in Q1 2026, selling an estimated $22.6M and leaving 27,466 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2156.
First Trust Advisors first reported a position in NVO in Q3 2013 and has held it in 49 quarters since. The position peaked at $66.7M in Q3 2022. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- First Trust Advisors held 27,466 shares of Novo Nordisk worth $1.01M as of Q1 2026.
- First Trust Advisors sold 476,069 Novo Nordisk shares in Q1 2026, an estimated $22.6M.
- Novo Nordisk made up ﹤0.01% of First Trust Advisors's portfolio in Q1 2026, its #2156 holding.
- First Trust Advisors first reported a position in Novo Nordisk in Q3 2013 and has held it in 49 quarters since.
- First Trust Advisors's Novo Nordisk position peaked at $66.7M in Q3 2022.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.